Eton Pharmaceuticals (ETON) Long-Term Deferred Tax (2018 - 2024)

Eton Pharmaceuticals has disclosed Long-Term Deferred Tax across 5 years of filings, most recently posting $404000.0 for Q4 2024.

• In Q4 2024, Long-Term Deferred Tax rose 139.05% year-over-year to $404000.0; the TTM figure through Dec 2024 stood at $404000.0 (up 139.05% YoY), while the FY2024 annual figure was $404000.0, up 139.05% from the prior year.
• Long-Term Deferred Tax came in at $404000.0 for Q4 2024 at Eton Pharmaceuticals, up from $169000.0 in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $18.5 million in Q4 2021 to a low of $169000.0 in Q4 2023.
• Average Long-Term Deferred Tax over 3 years is $6.4 million, with a median of $404000.0 recorded in 2024.
• The largest YoY upside for Long-Term Deferred Tax was 139.05% in 2024 against a maximum downside of 139.05% in 2024.
• Over 3 years, Long-Term Deferred Tax stood at $18.5 million in 2021, then tumbled by 99.09% to $169000.0 in 2023, then soared by 139.05% to $404000.0 in 2024.
• Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $404000.0 in Q4 2024, $169000.0 in Q4 2023, and $18.5 million in Q4 2021.